Vous avez cherché: aminolaevulinic (Maltais - Anglais)

5-aminolaevulinic acid użu fuq il-ġilda
5-aminolaevulinic acid cutaneous use

1 g ameluz fiha 78 mg ta 5-aminolaevulinic acid.
1 g ameluz contains 78 mg of 5-aminolaevulinic acid.

is-sustanza attiva hi 5-aminolaevulinic acid (bħala hydrochloride).
the active substance is 5-aminolaevulinic acid (as hydrochloride).

gramma ġel fiha 78 mg tal-5-aminolaevulinic acid (bħala hydrochloride).
one g gel contains 78 mg of 5-aminolaevulinic acid (as hydrochloride).

m’hemmx dejta mill-użu tal-5-aminolaevulinic acid f’nisa tqal.
there are no data from the use of 5-aminolaevulinic acid in pregnant women.

gramma (g) ġel fiha 78 mg tal-5-aminolaevulinic acid (bħala hydrochloride).
one gram (g) gel contains 78 mg of 5-aminolaevulinic acid (as hydrochloride).

ameluz ma jżidx il-livelli tal-5-aminolaevulinic acid jew tal-protoprophyrin ix plasma wara applikazzjoni topika.
ameluz does not increase 5-aminolaevulinic acid or protoprophyrin ix plasma levels following topical application.

ameluz ma għandux jingħata lil persuni li għandhom sensittività eċċessiva (allerġiċi) għal 5- aminolaevulinic acid, porfirini jew għal xi sustanzi oħra.
ameluz must not be given to people who are hypersensitive (allergic) to 5-aminolaevulinic acid, porphyrins, soybeans or peanuts, or any of the other ingredients.

mhux magħruf jekk il-5-aminolaevulinic acid jiġix eliminat mill-ħalib tas-sider tal-bniedem jew tal- annimali.
it is unknown whether 5-aminolaevulinic acid is excreted in human or animal milk.

dan huwa mistenni billi l-prinċipju terapewtiku tat-terapija fotodinamika huwa bbażat fuq l-effetti fototossiċi tal-protoporphyrin ix li hu sintetizzat mis-sustanza attiva l-5-aminolaevulinic acid.
this is to be expected as the therapeutic principle of photodynamic therapy is based on phototoxic effects of protoporphyrin ix which is synthesized from the active ingredient 5- aminolaevulinic acid.